CORE
šŗš¦Ā
Ā make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Evidence-based choice of ritonavir as index CYP3A inhibitor in drug-drug interaction studies
Authors
Aarnoutse
Culm-Merdek
+37Ā more
Eagling
Eichbaum
Englund
Gallant
Gallant
Greenblatt
Greenblatt
Greenblatt
Greenblatt
Greenblatt
Hafner
Hesse
Jiang
Katzenmaier
Ke
Kharasch
Kirby
Kirby
Klein
Kozakai
Lamorde
Liu
Mathias
Mathias
Morcos
Niwa
Niwa
Olkkola
Peltoniemi
Raschi
Sekar
Talakad
Tran
von Moltke
Walsky
Xu
Yeh
Publication date
Publisher
'Wiley'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1002%2Fjcph.609
Last time updated on 10/11/2020